ArticleVaccines2024
Immunogenicity of Tetravalent Protein Vaccine SCTV01E-2 against SARS-CoV-2 EG.5 Subvaraint: A Phase 2 Trial.
Jihai Tang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it
ArticleVaccines2024
Jihai Tang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.